Pacific Biosciences (PACB)

$1.42 +0.03 (2.16%)
Market Cap 399.11M
Revenue (ttm) 154.01M
Net Income (ttm) -309.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -201.19%
Debt to Equity Ratio 0.00
Volume 4,662,152
Avg Vol 9,470,182
Day's Range N/A - N/A
Shares Out 300.09M
Stochastic %K 21%
Beta 2.17
Analysts Sell
Price Target $2.00

Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleas...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 521 8000
Address:
1305 O’Brien Drive, Menlo Park, United States
Yooman
Yooman Aug. 5 at 6:50 PM
$PACB Thanks to PACB for the technology that is helping us to understand diseases better and better, making therapies such as this one possible: https://bsky.app/profile/isabelsantos.bsky.social/post/3lvngkzs74k2h
0 · Reply
TedsRocks
TedsRocks Aug. 5 at 4:54 PM
$PACB Let’s hope for a beat. Wall Street analysts expect Pacific Biosciences of California (PACB) to post quarterly loss of -$0.18 per share in its upcoming report, which indicates a year-over-year increase of 10%. Revenues are expected to be $36.46 million, up 1.3% from the year-ago quarter.
2 · Reply
jfun1
jfun1 Aug. 5 at 4:19 PM
$PACB no pre announcement. Im thinking a great update
1 · Reply
patten1962
patten1962 Aug. 5 at 3:46 PM
$PACB Feels like a lot of companies are using PacBio's tech. Just a matter of time until this translates into 💰💰💰
1 · Reply
Carmichael77
Carmichael77 Aug. 5 at 3:30 AM
$PACB @Razor_Ramon Looks like Razor is ready for PACB Q2 earnings!
2 · Reply
Razor_Ramon
Razor_Ramon Aug. 5 at 1:50 AM
$PACB The time has come. Significant traction needs to have occurred in Q2, especially, with their latest appiontees and fat trimming specialists. Christian Henry owes long time, loyal shareholders big time.
0 · Reply
patten1962
patten1962 Aug. 5 at 12:10 AM
$PACB Just got Ark's email. No PacBio sells.
1 · Reply
endo3
endo3 Aug. 4 at 9:24 PM
$PACB will this ever reach $13 again?
1 · Reply
Furderber
Furderber Aug. 4 at 9:08 PM
$PACB Hopefully the reduction in workforce and potential sales and optimal forecast will bode well for Thursday. If we can rally to $1.60 by Thursday we might see a double with a good earnings report. A negative earnings report and we are back between $1.2-$1.4 range based on technical analysis of passe support. But review mirrors are not the best to look at in order to see the road ahead.
0 · Reply
Carmichael77
Carmichael77 Aug. 4 at 8:46 PM
$PACB Cathie did not sell
2 · Reply
Latest News on PACB
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

Aug 4, 2025, 9:05 AM EDT - 1 day ago

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Jul 29, 2025, 8:52 AM EDT - 7 days ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

DGX

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Jul 24, 2025, 9:05 AM EDT - 12 days ago

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

Jul 23, 2025, 9:05 AM EDT - 13 days ago

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 21, 2025, 4:05 PM EDT - 15 days ago

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

Jun 2, 2025, 10:00 AM EDT - 2 months ago

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

May 12, 2025, 10:56 AM EDT - 3 months ago

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:08 PM EDT - 3 months ago

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

PacBio Announces First Quarter 2025 Financial Results

May 8, 2025, 4:15 PM EDT - 3 months ago

PacBio Announces First Quarter 2025 Financial Results

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

May 5, 2025, 9:05 AM EDT - 3 months ago

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

Apr 28, 2025, 9:05 AM EDT - 3 months ago

PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

Apr 22, 2025, 9:05 AM EDT - 3 months ago

Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

Apr 9, 2025, 9:05 AM EDT - 4 months ago

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

PacBio Grants Equity Incentive Award to New Employee

Apr 4, 2025, 7:45 PM EDT - 4 months ago

PacBio Grants Equity Incentive Award to New Employee

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Mar 27, 2025, 9:22 AM EDT - 4 months ago

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Jim Gibson to join PacBio as Chief Financial Officer

Mar 27, 2025, 9:05 AM EDT - 4 months ago

Jim Gibson to join PacBio as Chief Financial Officer

Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

Mar 17, 2025, 9:05 AM EDT - 5 months ago

Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock

Feb 25, 2025, 10:26 PM EST - 5 months ago

Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference

Feb 19, 2025, 4:05 PM EST - 5 months ago

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference

Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 9:09 PM EST - 6 months ago

Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript

Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 6 months ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN TXG

PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service

Feb 3, 2025, 9:05 AM EST - 6 months ago

PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

Jan 30, 2025, 4:05 PM EST - 6 months ago

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

PacBio Announces Appointment of Chris Smith to Board of Directors

Jan 30, 2025, 9:05 AM EST - 6 months ago

PacBio Announces Appointment of Chris Smith to Board of Directors

PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics

Jan 29, 2025, 9:05 AM EST - 6 months ago

PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics

PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider

Jan 23, 2025, 9:05 AM EST - 6 months ago

PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider

PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics

Jan 14, 2025, 9:05 AM EST - 7 months ago

PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics

PacBio Announces Preliminary Fourth Quarter and Full Year Revenue

Jan 14, 2025, 9:00 AM EST - 7 months ago

PacBio Announces Preliminary Fourth Quarter and Full Year Revenue

PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing

Jan 10, 2025, 6:05 AM EST - 7 months ago

PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing

PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:05 PM EST - 7 months ago

PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference

Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight

Dec 5, 2024, 8:54 AM EST - 8 months ago

Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition

Nov 12, 2024, 3:38 PM EST - 9 months ago

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition

PacBio to Present at Upcoming Investor Conferences

Nov 8, 2024, 4:05 PM EST - 9 months ago

PacBio to Present at Upcoming Investor Conferences

Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 9:04 PM EST - 9 months ago

Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

Nov 7, 2024, 4:03 PM EST - 9 months ago

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

Nov 6, 2024, 10:35 PM EST - 9 months ago

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

The Schall Law Firm Encourages Investors With Losses To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud

Nov 4, 2024, 11:00 AM EST - 9 months ago

The Schall Law Firm Encourages Investors With Losses To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud

The Schall Law Firm Encourages Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

Nov 2, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

Pacific Biosciences of California, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 31, 2024, 11:00 AM EDT - 9 months ago

Pacific Biosciences of California, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud

Oct 30, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud

Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep

Oct 30, 2024, 10:13 AM EDT - 9 months ago

Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep

PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

Oct 29, 2024, 9:05 AM EDT - 10 months ago

PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

Oct 28, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

The Schall Law Firm Invites Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

Oct 24, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud

PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

Oct 22, 2024, 9:05 AM EDT - 10 months ago

PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Possible Securities Fraud

Oct 20, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Possible Securities Fraud

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Pacific Biosciences of California Inc For Possible Securities Fraud

Oct 18, 2024, 11:00 AM EDT - 10 months ago

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Pacific Biosciences of California Inc For Possible Securities Fraud

Pacific Biosciences of California, Inc. Is Being Investigated For Securities Related Infractions And The Schall Law Firm Urges Impacted Shareholders To Reach Out

Oct 17, 2024, 11:00 AM EDT - 10 months ago

Pacific Biosciences of California, Inc. Is Being Investigated For Securities Related Infractions And The Schall Law Firm Urges Impacted Shareholders To Reach Out

Yooman
Yooman Aug. 5 at 6:50 PM
$PACB Thanks to PACB for the technology that is helping us to understand diseases better and better, making therapies such as this one possible: https://bsky.app/profile/isabelsantos.bsky.social/post/3lvngkzs74k2h
0 · Reply
TedsRocks
TedsRocks Aug. 5 at 4:54 PM
$PACB Let’s hope for a beat. Wall Street analysts expect Pacific Biosciences of California (PACB) to post quarterly loss of -$0.18 per share in its upcoming report, which indicates a year-over-year increase of 10%. Revenues are expected to be $36.46 million, up 1.3% from the year-ago quarter.
2 · Reply
jfun1
jfun1 Aug. 5 at 4:19 PM
$PACB no pre announcement. Im thinking a great update
1 · Reply
patten1962
patten1962 Aug. 5 at 3:46 PM
$PACB Feels like a lot of companies are using PacBio's tech. Just a matter of time until this translates into 💰💰💰
1 · Reply
Carmichael77
Carmichael77 Aug. 5 at 3:30 AM
$PACB @Razor_Ramon Looks like Razor is ready for PACB Q2 earnings!
2 · Reply
Razor_Ramon
Razor_Ramon Aug. 5 at 1:50 AM
$PACB The time has come. Significant traction needs to have occurred in Q2, especially, with their latest appiontees and fat trimming specialists. Christian Henry owes long time, loyal shareholders big time.
0 · Reply
patten1962
patten1962 Aug. 5 at 12:10 AM
$PACB Just got Ark's email. No PacBio sells.
1 · Reply
endo3
endo3 Aug. 4 at 9:24 PM
$PACB will this ever reach $13 again?
1 · Reply
Furderber
Furderber Aug. 4 at 9:08 PM
$PACB Hopefully the reduction in workforce and potential sales and optimal forecast will bode well for Thursday. If we can rally to $1.60 by Thursday we might see a double with a good earnings report. A negative earnings report and we are back between $1.2-$1.4 range based on technical analysis of passe support. But review mirrors are not the best to look at in order to see the road ahead.
0 · Reply
Carmichael77
Carmichael77 Aug. 4 at 8:46 PM
$PACB Cathie did not sell
2 · Reply
KalliTRiTe
KalliTRiTe Aug. 4 at 8:19 PM
$PACB
0 · Reply
biochirp
biochirp Aug. 4 at 7:51 PM
$PACB who is gonna acquire this company? Thermo? Illumina?
1 · Reply
Carmichael77
Carmichael77 Aug. 4 at 7:48 PM
$PACB 40-page pdf link to The Platinum Pedigree: A long-read benchmark for genetic variants for AI + PacBio insights https://www.biorxiv.org/content/biorxiv/early/2024/10/03/2024.10.02.616333.full.pdf
0 · Reply
breaktime
breaktime Aug. 4 at 7:38 PM
$PACB Looking forward to seeing what this can do over time
1 · Reply
Carmichael77
Carmichael77 Aug. 4 at 7:31 PM
$PACB AI + PacBio https://www.stocktitan.net/news/PACB/nature-methods-paper-leverages-pac-bio-sequencing-technology-to-fu7zy5987otq.html
2 · Reply
Autumn34
Autumn34 Aug. 4 at 6:04 PM
$PACB no she did not
3 · Reply
Takoda
Takoda Aug. 4 at 3:55 PM
$PACB Cathie sold the lot on Friday, including our beloved Pacific Bioscience. Cuz definitely she was spooked by the jobs report and the weight of tariffs. Let's see what she does today.
3 · Reply
Takoda
Takoda Aug. 4 at 3:33 PM
$PACB since I'm not able to post photos on Yahoo, people from Yahoo can actually see the trading action of Cathie. Really disappointed with the information smothering Yahoo is doing. They are becoming a fascist news regulator?
0 · Reply
IvansDrivin
IvansDrivin Aug. 4 at 3:16 PM
$PACB Already at the low end of my original projection. I don't see it going lower than 1.27, unless they royally fuck up earnings. Should be 1.80+ after ER.
1 · Reply
Takoda
Takoda Aug. 4 at 2:29 PM
$PACB I really can't stand the tactics of hedge funds. Companies like BlackRock and Vanguard own the stock and then they short the stock. It gives them access to free up shares when the short position isn't good. But I guess this is how the system is designed, the rich get richer
0 · Reply
x404
x404 Aug. 4 at 1:34 PM
$PACB https://api.quotemedia.com/supplement/news-story/?webmasterId=102291&storyId=6255025148696715
1 · Reply
patten1962
patten1962 Aug. 4 at 10:27 AM
$PACB God this is such a big week for this stock.
1 · Reply